Analyst: Discouraging announcement from Sonova puts spotlight on GN
The hearing aid giant’s downgrade could potentially impact its Danish competitors, says a Sydbank analyst.
by marketwire, translated by daniel pedersen
The world’s biggest hearing aid manufacturer, Swiss Sonova, on Tuesday downgraded its full-year expectations for 2022/2023, citing a weak private market in the US and high freight and component costs.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Demant downgrades after revenue disappoints
For subscribers
